PATH UiPath (PATH) Insider Trading, Ownership & Congress Trades
Software & IT · Services-prepackaged software · CIK 0001734722
Form 144 · 10
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
280
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $0 priced
What the filings say about PATH
Insiders, 180 days
-$62.0M net sold
5 sellers · 85% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$61.4M
10 notices
UiPath insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, UiPath, Inc. insiders sold a net $62.0M of stock across 252 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Oct 9, 2026.
- The trade is 2.0% of the 1,484,716 shares held after it.
- 3 other insiders sold within 30 days.
- 280 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CPO & CTO Malpani Raghavendra sold about $414.0K of PATH under a 10b5-1 plan on Oct 22, 2026; 3 other insiders sold within 30 days and 280 funds added in the latest 13F quarter.Context
- 125 earlier Form 4 trades (code P or S) here by this insider (125 sales), the last on Oct 15, 2026.
- The trade is 4.1% of the 29,038,838 shares held after it.
- 3 other insiders sold within 30 days.
- 280 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO and Chairman Dines Daniel sold about $15.6M of PATH under a 10b5-1 plan on Oct 16, 2026; 3 other insiders sold within 30 days and 280 funds added in the latest 13F quarter.Context
- 125 earlier Form 4 trades (code P or S) here by this insider (125 sales), the last on Oct 15, 2026.
- The trade is 0.2% of the 28,991,238 shares held after it.
- 3 other insiders sold within 30 days.
- 280 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO and Chairman Dines Daniel sold about $658.4K of PATH under a 10b5-1 plan on Oct 16, 2026; 3 other insiders sold within 30 days and 280 funds added in the latest 13F quarter.Context
- 124 earlier Form 4 trades (code P or S) here by this insider (124 sales), the last on Aug 19, 2026.
- The trade is 4.1% of the 30,241,238 shares held after it.
- 3 other insiders sold within 30 days.
- 280 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO and Chairman Dines Daniel sold about $16.8M of PATH under a 10b5-1 plan on Oct 15, 2026; 3 other insiders sold within 30 days and 280 funds added in the latest 13F quarter.Context
- 10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Dec 5, 2025.
- The trade is 2.6% of the 1,066,107 shares held after it.
- 3 other insiders sold within 30 days.
- 280 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal & Admin Officer Brubaker Brad sold about $373.6K of PATH under a 10b5-1 plan on Oct 12, 2026; 3 other insiders sold within 30 days and 280 funds added in the latest 13F quarter.252 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$62.0M over 180 days
-$62.0M over 90 days · -$55.6M of it by a 10%+ holder
below 87% of Software & IT
Congress
no House purchase disclosed in the last 12 months
Funds
280 funds bought in last quarter
more than 84% of Software & IT
Revenue
+12.7% year over year
more than 57% of Software & IT
Margin
17.5% net margin
more than 82% of Software & IT
Buybacks
$268.5M repurchased, FY to 2026-07-31
more than 73% of Software & IT
Short interest
27.8% of the float short (float per yahoo 2026-10-26) · 2.3 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 26CPO & CTO Malpani Raghavendra sold $813.2K under a 10b5-1 plan (2 trades, Oct 9 to Oct 22)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 19CEO and Chairman Dines Daniel sold $33.1M under a 10b5-1 plan (3 trades, Oct 15 to Oct 16)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 15Director ICEVULCAN INVESTMENTS LIMITED filed to sell $32.6M by Oct 15 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 5COO Gupta Ashim sold $869.8K under a 10b5-1 plan (Oct 2)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 2Officer Ashim Gupta filed to sell $879.8K by Oct 2 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Watch PATH
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-6.0%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns PATH: institutional holders (13F)
13F holdings, latest reported quarter
46,153,124 sh
$501.7M
30,950,000 sh
$336.4M
26,320,700 sh
$286.1M
18,710,688 sh
$203.4M
15,034,443 sh
$163.4M
Congress trades in PATH
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
PATH planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
RAGHAVENDRA MALPANI
Filed 2026-10-22
$405.3K
ICEVULCAN INVESTMENTS LIMITED
Filed 2026-10-15
$32.6M
BRAD C BRUBAKER
Filed 2026-10-13
$369.4K
RAGHAVENDRA MALPANI
Filed 2026-10-09
$391.7K
Ashim Gupta
Filed 2026-10-02
$879.8K
PATH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fundstrat Granny Shots US Small- & Mid-Cap ETF
$10.7M position · as of 2026-07-31
2.1%
Avory Foundational ETF
$1.1M position · as of 2026-05-29
1.9%
First Trust Small Cap BuyWrite Income ETF
$458.5K position · as of 2026-06-30
1.9%
VanEck Social Sentiment ETF
$1.7M position · as of 2026-06-30
1.6%
Mid Cap Intrinsic Value Portfolio
$1.6M position · as of 2026-06-30
1.4%
First Trust Nasdaq Artificial Intelligence and Robotics ETF
$10.1M position · as of 2026-06-30
1.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Dines
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.3M
$1.3M
$5.7M
-82%
+132%
2021
$669.6K
$669.6K
$18.7M
-47%
+14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $62.0M sold by insiders over 180 days, 280 funds added last quarter, $61.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
PATH financials
Revenue growth
+12.7%
XBRL, annual
Net margin
17.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.7B
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM PATH
| FY Jan 2026 | $1.6B |
| FY Jan 2025 | $1.4B |
| FY Jan 2024 | $1.3B |
| FY Jan 2023 | $1.1B |
| FY Jan 2022 | $892.3M |
| Jul 2026 | $410.3M |
| Apr 2026 | $418.4M |
| Jan 2026 | $481.1M |
| Oct 2025 | $411.1M |
| Jul 2025 | $361.7M |
| Apr 2025 | $356.6M |
| Jan 2025 | $423.6M |
| Oct 2024 | $354.7M |
At each fiscal year end
Single quarter
Net margin, TTM
+21.0%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM PATH
| FY Jan 2026 | +17.5% |
| FY Jan 2025 | -5.2% |
| FY Jan 2024 | -6.9% |
| FY Jan 2023 | -31.0% |
| FY Jan 2022 | -58.9% |
| Jul 2026 | +8.8% |
| Apr 2026 | +5.4% |
| Jan 2026 | +21.7% |
| Oct 2025 | +48.4% |
| Jul 2025 | +0.4% |
| Apr 2025 | -6.3% |
| Jan 2025 | +12.2% |
| Oct 2024 | -3.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$363.0M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM PATH
| FY Jan 2026 | $352.2M |
| FY Jan 2025 | $305.6M |
| FY Jan 2024 | $291.7M |
| FY Jan 2023 | -$33.8M |
| FY Jan 2022 | -$63.8M |
| Jul 2026 | $29.3M |
| Apr 2026 | $129.2M |
| Jan 2026 | $179.3M |
| Oct 2025 | $25.1M |
| Jul 2025 | $41.6M |
| Apr 2025 | $106.2M |
| Jan 2025 | $138.7M |
| Oct 2024 | $23.2M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity PATH
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Jan 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt PATH
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Jan 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+20.0%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity PATH
| FY Jan 2026 | +14.4% |
| FY Jan 2025 | -3.8% |
| FY Jan 2024 | -4.6% |
| FY Jan 2023 | -17.1% |
| FY Jan 2022 | -94.0% |
| Jul 2026 | +20.0% |
| Apr 2026 | +18.2% |
| Jan 2026 | +14.4% |
| Oct 2025 | +12.6% |
| Jul 2025 | +1.2% |
| Apr 2025 | -3.6% |
| Jan 2025 | -3.8% |
| Oct 2024 | -5.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+13.2%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets PATH
| FY Jan 2026 | +9.3% |
| FY Jan 2025 | -2.5% |
| FY Jan 2024 | -3.2% |
| FY Jan 2023 | -12.4% |
| FY Jan 2022 | -30.6% |
| Jul 2026 | +13.2% |
| Apr 2026 | +11.8% |
| Jan 2026 | +9.3% |
| Oct 2025 | +8.3% |
| Jul 2025 | +0.8% |
| Apr 2025 | -2.5% |
| Jan 2025 | -2.5% |
| Oct 2024 | -3.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -72%, not meaningful
Return on invested capital PATH
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Jan 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.7%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed PATH
| FY Jan 2026 | +2.6% |
| FY Jan 2025 | -7.5% |
| FY Jan 2024 | -7.6% |
| FY Jan 2023 | -16.8% |
| FY Jan 2022 | -39.3% |
| Jul 2026 | +7.7% |
| Apr 2026 | +5.1% |
| Jan 2026 | +2.6% |
| Oct 2025 | +0.5% |
| Jul 2025 | -2.4% |
| Apr 2025 | -6.2% |
| Jan 2025 | -7.5% |
| Oct 2024 | -8.8% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
21.09x
close 2026-10-23 over four quarters of diluted EPS, 2025-08-01 to 2026-07-31
P/E, trailing PATH
| FY Jan 2026 | 24.21x |
| FY Jan 2025 | n/a |
| FY Jan 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Jul 2026 | 19.04x |
| Apr 2026 | 17.17x |
| Jan 2026 | 24.21x |
| Oct 2025 | 37.76x |
| Jul 2025 | 391.67x |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value PATH
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Jan 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield PATH
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Jan 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.01x
P/E over trailing EPS growth of 2133%: four quarters to 2026-07-31 against the four to 2025-07-31
PEG, trailing PATH
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Jan 2024 | n/a |
| FY Jan 2023 | n/a |
| FY Jan 2022 | n/a |
| Jul 2026 | 0.01x |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-01 | 2025-01 | 2024-01 | 2023-01 | |
|---|---|---|---|---|
| Revenue | $1.6B | $1.4B | $1.3B | $1.1B |
| Gross profit | $1.3B | $1.2B | $1.1B | $878.5M |
| Operating income | $56.8M | -$162.6M | -$164.7M | -$348.3M |
| Net income | $282.3M | -$73.7M | -$89.9M | -$328.4M |
| EPS (diluted) | 0.52 | -0.13 | -0.16 | -0.60 |
| Operating cash flow | $371.2M | $320.6M | $299.1M | -$10.0M |
| Cash | $871.2M | $879.2M | $1.1B | $1.4B |
| Buybacks | $329.1M | $390.8M | $102.6M | $0 |
SEC XBRL, fiscal years, as known on 2026-10-27
PATH Stock Sonar score 5/7 axes
Find similar shapesComparePATH ranks highest on profitability (77th percentile) and institutional and government (68th), and lowest on insider conviction (28th), among Software & IT peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PATH filings, in plain words
Are UiPath insiders buying or selling PATH?
In the 180 days to 2026-10-27, UiPath insiders were net sellers, a net $62.0M across purchases and sales reported on Form 4, by 5 sellers.
Are there planned insider sales of PATH?
Yes. 10 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $61.4M of stock; the latest, by RAGHAVENDRA MALPANI, was filed 2026-10-22.
Read the full summary
In the 180 days to 2026-10-27, UiPath insiders were net sellers of PATH, a net $62.0M across purchases and sales reported on Form 4 by 5 sellers. Most of that figure, $55.6M, came from a holder of 10% or more rather than an officer or director. 85% of the 13 insider sales were made under a pre-arranged Rule 10b5-1 plan, so most selling was scheduled in advance. Insiders filed 10 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $61.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
